Advertisement

Picture EBD Group BioPharm America 2019 Boston September 600x60px

News > All

Total search results: 9789 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 72 73 74 ... 96 97 98  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Lonza. (4/12/12). "Press Release: Lonza and Agennix Sign Development and Manufacturing Deal for Production of Talactoferrin". Basel, Planegg, Princeton, NJ & Houston, TX. 2012-04-12
Immatics Biotechnologies GmbH. (4/12/12). "Press Release: Immatics Appoints Dr Rainer Kramer as Chief Business Officer". Tübingen. 2012-04-12
Wilex AG. (4/12/12). "Press Release: Wilex Publishes Financial Report for the First Quarter of 2012. Rights Issue Successfully Concluded – Process for Final Analysis of Rencarex Started – Revenue and Earnings Improved". Munich. 2012-04-12
Roche. (4/12/12). "Press Release: Roche Issues Statement Regarding Illumina Offer". Basel. 2012-04-12
Roche. (4/12/12). "Press Release: Roche on Track for Full-year Targets – Good Sales Growth in First Quarter". Basel. 2012-04-12
Messe München GmbH. (4/11/12). "Press Release: Analytica 2012. Mobile App for Optimum Trade-fair Planning". 2012-04-11
Bayer AG. (4/11/12). "Press Release: Bayer Updates U.S. Labels for Drospirenone-containing Combined Oral Contraceptives [not intended for U.S. and UK media]". Berlin. 2012-04-11
Santhera Pharmaceuticals. (4/11/12). "Press Release: Santhera Joins EU-funded EndoStem Consortium in Preparation for Clinical Study with Omigapil in Cogenital Muscular Dystrophies". Liestal. 2012-04-11
Epigenomics AG. (4/11/12). "Press Release: Epigenomics AG Enrolls First Participants in Its FIT Comparative Study with Epi proColon". Berlin & Seattle, WA. 2012-04-11
Lonza Group Ltd.. (4/11/12). "Press Release: Lonza Launches Next Generation Vegetarian DHA". Basel. 2012-04-11
Aleva Neurotherapeutics S.A.. (4/10/12). "Press Release: Aleva Neurotherapeutics Raises CHF 4.0 Million Series B Financing Round. Lead Investor Banexi Ventures Partners Joins Strong Investment Consortium". Lausanne. 2012-04-10
MeVis Medical Solutions AG. (4/10/12). "Press Release: MeVis Medical Solutions AG Announces the Resignation of Executive Board Member Thomas Tynes". Bremen. 2012-04-10
Illumina, Inc.. (4/10/12). "Press Release: Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote for the Election of All Illumina Nominees Using Management’s White Proxy Card". San Diego, CA. 2012-04-10
Immutep S.A.. (4/10/12). "Press Release: Immutep and Lonza Sign Agreement for Cell Line Selection, Cell Banking and Process Development of ImmuFact IMP321". Basel & Orsay. 2012-04-10
SAW Instruments GmbH. (4/10/12). "Press Release: SAW Instruments Launches samX Biosensor Access Program. Lease the High-end samX for Six Months with No Capital Spend". Bonn. 2012-04-10
TiGenix N.V.. (4/10/12). "Press Release: TiGenix Appoints Dr. Guido Schopen as Vice President Commercial Operations". Leuven. 2012-04-10
Illumina, Inc.. (4/9/12). "Press Release: Illumina’s Board of Directors Sends Fourth Letter to Stockholders. Recommends Stockholders Reject Roche’s Offer and Vote White Proxy Card". San Diego, CA. 2012-04-09
Illumina, Inc.. (4/6/12). "Press Release: Leading Proxy Advisory Firms Issue Reports in Strong Support of Illumina. ISS Conludes Roche’s Offer Is Inadequate". San Diego, CA. 2012-04-06
UMIT – Private Universität für Gesundheitswissenschaften, Medizinische Informatik und Technik GmbH. (4/5/12). "Pressemitteilung: Evidenzbasierte Medizin als Thema einer hochkarätigen Tagung an der Health & Life Sciences Universität UMIT in Hall". Hall in 2012-04-05
Socorex Isba S.A.. (4/5/12). "Press Release: New – Rotarary Work Station. Twister universal 336". 2012-04-05
Biofrontera AG. (4/4/12). "Press Release: Biofrontera and Bipharma Sign Exclusive Marketing and Distribution Agreement for Ameluz for the Benelux". Leverkusen. 2012-04-04
High-Tech Gründerfonds Management GmbH. (4/4/12). "Press Release: ZIM Plant Technology GmbH. High-Tech Gründerfonds Invests in Intelligent Monitoring Solution to Monitor the Actual Water Requirements of Plants in Real Time". Hennigsdorf, Potsdam & Bonn. 2012-04-04
Noxxon Pharma AG. (4/4/12). "Press Release: Noxxon’s NOX-A12 Delays Glioblastoma Recurrence in Preclinical Model. Data Presented at the American Association for Cancer Research (AACR) Annual Meeting 2012". Berlin. 2012-04-04
DataApex. (4/4/12). "Press Release: DataApex Announces German Localization of Clarity". Prague. 2012-04-04
Xencor, Inc.. (4/4/12). "Press Release: Xencor Receives Second Milestone Payment from Boehringer Ingelheim under Antibody Technology License Agreement". Monrovia, CA. 2012-04-04
Kadimastem Ltd.. (4/4/12). "Press Release: Pharmaceutical Company Merck Serono Signs an Agreement to Use Kadimastem’s Platform for Drug Screening". Nes Ziona. 2012-04-04
Messe München GmbH. (4/3/12). "Press Release: Analytica. Diverse Range of Information in Related-events Program". 2012-04-03
Bayer AG. (4/3/12). "Press Release: Phase III Trial of Regorafenib in Patients with Metastatic Gastrointestinal Stromal Tumors (GIST) Meets Primary Endpoint of Improving Progression-free Survival [not intended for U.S. and UK media]". Berlin. 2012-04-03
Lonza Group Ltd.. (4/3/12). "Press Release: Lonza Appoints Richard Ridinger as New CEO". Basel. 2012-04-03
Analytik Jena AG. (4/3/12). "Press Release: AJ Blomesystem Launches New Laboratory Information Management System readyLIMS on the Market". Jena. 2012-04-03
Lonza Group Ltd.. (4/3/12). "Press Release: Annual General Meeting of Lonza Group Ltd.". Basel. 2012-04-03
4SC AG. (4/2/12). "Press Release: Henkel and 4SC Discovery Start Research Collaboration in Compound Screening". Planegg-Martinsried. 2012-04-02
Bicycle Therapeutics Ltd.. (4/2/12). "Press Release: Bicycle Therapeutics Appoints Rolf H. Günther, M.D., Ph.D., as CEO". Cambridge. 2012-04-02
PerkinElmer, Inc.. (4/2/12). "Press Release: PerkinElmer Launches HER2Sense Discovery Research Imaging Agent to Enable Personalized Medicine Approaches for Breast Cancer Research". Waltham, MA. 2012-04-02
Roche. (4/2/12). "Press Release: Roche Boosts Laboratory Workflow with cobas p 312 Pre-analytical System. Entering into a New Dimension of Sample Automation with Space-saving Solutions". Rotkreuz. 2012-04-02
Actelion Ltd.. (4/2/12). "Press Release: Japan’s Ministry of Health, Labour and Welfare Grants Approval for Actelion’s Miglustat for the Treatment of Niemann-Pick Type C Disease". Allschwil. 2012-04-02
Actelion Ltd.. (4/2/12). "Press Release: Actelion Provides Update on CRTH2 Program". Allschwil. 2012-04-02
AiCuris GmbH & Co. KG. (4/2/12). "Press Release: Results of Letermovir (AIC246) Phase 2b in Prophylaxis of Human Cytomegalovirus in Recipients of Human Blood Precursor Cell Transplants Meeting both Primary Efficacy Endpoints to Be Presented at Internatio 2012-04-02
MorphoSys AG. (4/2/12). "Press Release: MorphoSys to Start Share Buy-back Program". 2012-04-02
Bruker Corporation. (3/31/12). "Press Release: Bruker and University Medical Center Groningen (UMCG) Announce a Collaboration within New European Network for Rapid Identification of Anaerobes (ENRIA)". London. 2012-03-31
Bruker Corporation. (3/31/12). "Press Release: Bruker Expands MALDI Biotyper Capabilities with New Protocols and Reference Libraries for Myobacteria and Multicellilar Fungi". London. 2012-03-31
Biofrontera AG. (3/30/12). "Press Release: Biofrontera Publishes Financial Report 2011". Leverkusen. 2012-03-30
Peak Scientific Instruments Ltd.. (3/30/12). "Press Release: Peak Scientific Launches the Genius 1022 Nitrogen Generator". 2012-03-30
Ruhr-Universität-Bochum. (3/30/12). "Press Release: ADHD Is Over-diagnosed. Researchers at RUB and University of Basel Provide Uprecedented Reliable Data". Bochum. 2012-03-30
John Wiley & Sons. (3/30/12). "Press Release: Announcing the Wiley Registry of Tandem MS Data, MSforID". Hoboken, NJ. 2012-03-30
Medigene AG. (3/30/12). "Press Release: Medigene’s Drug Veregen Obtains Market Approval in Switzerland. Market Launch Planned during 2012". Martinsried. 2012-03-30
Biofrontera AG. (3/29/12). "Press Release: Biofrontera and Allergan Sign Marketing and Distribution Agreement for Ameluz in Spain". Leverkusen. 2012-03-29
4SC AG. (3/29/12). "Press Release: 4SC Announces Financial Results 2011". Planegg-Martinsried. 2012-03-29
Norgenta Norddeutsche Life Science Agentur. (3/29/12). "Pressemitteilung: Tropenkrankheiten schnell und sicher erkennen – weltweit einmaliges Projekt in Hamburg setzt Standards bei Diagnostika". Hamburg. 2012-03-29
Protagen AG. (3/29/12). "Press Release: Protagen Counts on Kairos Expertise in Biobank-Management". 2012-03-29
Bayer AG. (3/28/12). "Press Release: 103rd Annual Meeting American Association for Cancer Research. Bayer to Present New Data on Oncology Pipeline [no US + UK Media]". Berlin. 2012-03-28
University of Oslo. (3/28/12). "Blog: Bioanalytics@UiO. Orbitrap Mass Spectrometer Arrived!". 2012-03-28
GATC Biotech AG. (3/28/12). "Press Release: GATC Biotech’s NightXpress Sequencing Service Goes Europe-wide. New Cologne Laboratories Bring GATC Biotech Closer to Its Customers". 2012-03-28
Stratec Biomedical AG. (3/28/12). "Press Release: Stratec Posts Record Sales for 2011. Sales at € 116.6 Million (+14.3%; previous Year: € 102.0m)". Birkenfeld. 2012-03-28
Qiagen. (3/28/12). "Press Release: Qiagen Obtains SFDA Registration for QIAsymphony SP System. QIAsymphony SP Is the Second Instrument om Qiagen’s QIAsymphoy RGQ Platform to Be Registered in China". Shanghai & Beijing. 2012-03-28
Promethera Biosciences S.A.. (3/28/12). "Press Release: Promethera Biosciences Raises EUR 23.6 Million (~ USD 31.4 Million) in Series-B Financial Round". Mont-Saint-Guibert. 2012-03-28
Bayer AG. (3/27/12). "Press Release: Bayer HealthCare and Beijing’s Tsinghua University Extend Innovative Drug Discovery Partnership". Beijing. 2012-03-27
Cartagenia N.V.. (3/27/12). "Press Release: Cartagenia Announces the Release of Its Bench Lab NGS Solution for Clinical NGS Data Analysis". Leuven. 2012-03-27
Bruker Corporation. (3/27/12). "Press Release: Bruker Introduces WineScreener – a Cost-effective, Automated and High Throughput Solution for Wine Quality Control and Safety Checks Using High-resolution FT-NMR". Cologne. 2012-03-27
MagForce AG. (3/26/12). "Press Release: MagForce AG Announces Company Restructuring and Revised Corporate Strategy for 2012. Greater Emphasis on Clinical Development to Provide Key Physicians with Access to NanoTherm Therapy". Berlin. 2012-03-26
ImaginAb, Inc.. (3/26/12). "Press Release: ImaginAb Concludes $12.5m Series A Financing". Los Angeles, CA. 2012-03-26
Bayer AG. (3/26/12). "Press Release: Treatment of Pulmonary Embolism (PE). Bayer’s Xarelto (Rivaroxaban) Proven Effective in Treating Patients with Pulmonary Embolism and in Preventing Recurrent Venouos Blood Clots in Phase III EINSTEIN-PE Study [no US + 2012-03-26
Celtic Therapeutics Management L.L.L.P.. (3/26/12). "Press Release: Celtic Therapeutics Launches $50M Antibody Drug Conjugates Development Company with 10 ADC Development Programs". New York, NY, Lausanne & London. 2012-03-26
Genedata AG. (3/26/12). "Press Release: Chugai Pharmaceutical Extends Multi-year Licensing of Genedata Expressionist. Japan’s Leading Pharmaceutical Company for Oncological Therapies Expands Use of Genedata Expressionist". Basel & Tokyo. 2012-03-26
PBI-Dansensor A/S. (3/26/12). "Press Release: PBI-Dansensor Forms Sales Partnership with Sartorius". Ringsted & Göttingen. 2012-03-26
Medigene AG. (3/23/12). "Press Release: MediGene Reports Positive 2011 Fiscal Year Results". Martinsried. 2012-03-23
Epigenomics AG. (3/23/12). "Press Release: Epigenomics AG. Full Year Results for the Year Ended 31 December 2011". Berlin & Seattle, WA. 2012-03-23
Bayer AG. (3/23/12). "Press Release: Food Chain Partnership Project Reaches Milestone. First High-quality Indian Table Grapes from Cooperation between Bayer CropScience and Univeg Shipped to Europe". Monheim. 2012-03-23
Biofrontera AG. (3/23/12). "Press Release: Biofrontera AG – 4,402,682 Shares Subscribed in Capital Increase [Ad hoc release]". Leverkusen. 2012-03-23
Eurofins Scientific. (3/23/12). "Press Release: Eurofins Enters into an Agreement to Acquire QTA and a Supply Agreement with BASF". Des Moines, IO. 2012-03-23
Biocrates Life Sciences AG. (3/23/12). "Pressemitteilung: Zweiter Platz für acib beim Science2business-Award. Biocrates Life Sciences AG maßgebender Projektpartner". Innsbruck. 2012-03-23
Biotest AG. (3/22/12). "Press Release: BT-062 Demonstrates Rapid and Complete Tumor Eradication in Preclinical Studies. Pronounced Anti-tumor Activity against Aggressive Solid Tumors". Dreieich. 2012-03-22
Biotest AG. (3/22/12). "Press Release: Biotest Reached an All-time High Profit after Tax". Dreieich. 2012-03-22
Biotest AG. (3/22/12). "Press Release: Presentation. Press and Analyst Conference – Financial Year 2011". Dreieich. 2012-03-22
Paion AG. (3/22/12). "Press Release: Paion Signed Exclusive Option Agreement with Yichang for Remimazolam in China. Upfront Payments in the Total Amount of EUR 3 Million Subject to Signing of the Final Licensing Agreement". Aachen. 2012-03-22
Qiagen N.V.. (3/22/12). "Press Release: Qiagen and Bio-X Center Collaborate to Open Translational Medicine Lab in Shanghai. Collaboration Aims to Turn Biological Research into Diagnostics and Drugs that Optimize Patient Care". Shanghai. 2012-03-22
Messe München GmbH. (3/22/12). "Press Release: Analytica Presents Biotechnology Highlights". 2012-03-22
Curetis AG. (3/22/12). "Press Release: Curetis AG to Present Its Unyvero System for Pneumonia Diagnostics". Holzgerlingen. 2012-03-22
Evolva Holding S.A.. (3/22/12). "Press Release: Evolva Reports Financial Results for 2011. Saffron – New Product in Nutrition Pipeline, Further Shift Towards Nutrition and Consumer Products". Reinach. 2012-03-22
Evolva Holding S.A.. (3/22/12). "Presentation: Evolva 2011 Update. Improving Lives with Biosynthetic Technologies". Reinach. 2012-03-22
Sony DADC. (3/21/12). "Press Release: Shimadzu/Kratos and Sony DADC Sign New Agreement to Extend Collaboration". Manchester. 2012-03-21
High-Tech Gründerfonds Management GmbH. (3/21/12). "Press Release: Maxwell Biotech Venture Fund Invests in Hepatitis B/D Clinical Program. Co-invests with Germany’s Public/Private High-Tech Gründerfonds, One of Europe’s Top Venture Funds". Moscow & Bonn. 2012-03-21
Cartagenia N.V.. (3/21/12). "Press Release: Cartagenia Signs Two New US Customers and Appoints Drew Arnold as VP North America". Leuven. 2012-03-21
Cytos Biotechnology AG. (3/21/12). "Press Release: Cytos to Raise up to CHF37 Million from International and Strategic Investors to Advance Asthma Clinical Program [Not for release in US, Canada, Japan or Australia]". Schlieren. 2012-03-21
Evonik Industries AG. (3/21/12). "Press Release: Evonik Expands Research Cooperation in the Area of Catalysis". Essen. 2012-03-21
Addex Therapeutics S.A.. (3/21/12). "Press Release: Addex Changes Name to Addex Therapeutics". Geneva. 2012-03-21
Addex Therapeutics S.A.. (3/21/12). "Press Release: Addex Reports Positive Top Line Phase IIa Data for Dipraglurant in Parkinson’s Disease Levodopa-induced Dyskinesia (PD-LID)". Geneva. 2012-03-21
Scienion AG. (3/20/12). "Press Release: Scienion Introduces sciREADER CL for Colorimetric Detection of Multiplex Assays". Dortmund & Berlin. 2012-03-20
Evotec AG. (3/20/12). "Press Release: Evotec FY 2011. Significant Growth and Focused Investments Drive Profitability and Innovation". Hamburg. 2012-03-20
High-Tech Gründerfonds Management GmbH. (3/20/12). "Press Release: Evonik Industries Invests in High-Tech Gründerfonds II". Bonn. 2012-03-20
Ablynx N.V.. (3/20/12). "Press Release: Ablynx Announces an Extension of Its Global Strategic Nanobody Alliance with Boehringer Ingelheim". Ghent. 2012-03-20
Definiens AG. (3/19/12). "Press Release: Definiens Expands Stereology Capabilities for Quantitative Digital Pathology". Munich. 2012-03-19
ThromboGenics N.V.. (3/16/12). "Press Release: ThromboGenics Enters into Commercialization Agreement for Ocriplasmin with Alcon Outside the United States". Leuven. 2012-03-16
Bayer AG. (3/15/12). "Press Release: U.S. FDA Approves Natazia as the First Combined Oral Contraceptive to Treat Heavy Menstrual Bleeding (HMB) [Not intended for US and UK Media]". Berlin. 2012-03-15
CCS Cell Culture Service GmbH. (3/15/12). "Press Release: Chromotek and Cell Culture Service Enter into a Partnership to Market Chromobody Cell Lines". Martinsried & Hamburg. 2012-03-15
Protagen AG. (3/15/12). "Press Release: Protagen and NMI Announce Co-development of Multiplex Assays". 2012-03-15
Qiagen N.V.. (3/15/12). "Press Release: Qiagen Welcomes Change of a Major U.S. Guideline to Recommend HPV Testing as Part of Cervical Cancer Screening". Germantown, MD & Hilden. 2012-03-15
U.S. Preventive Services Taks Force. (3/15/12). "Press Release: U.S. Preventive Services Task Force Issues New Cervical Cancer Screening Recommendations. Evidence Shows that Cervical Cancer Screening Is Effective". 2012-03-15
Ion Beam Applications S.A. (IBA). (3/15/12). "Press Release: 2011 Annual Results. Refocusing on Radiotherapy – Growth of Almost 50% in Protontherapy". Louvain-la-Neuve. 2012-03-15
Invest in Bavaria. (3/15/12). "Press Release: Myriad Genetics Opens European Central Laboratory in Martinsried. Zeil: »Forward-pointing Innovation Policy Makes Bavaria Convincing«". Munich & Martinsried. 2012-03-15
next pagenext page 1 2 3 ... 72 73 74 ... 96 97 98  next pagenext page



Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group BioPharm America 2019 Boston September 600x60px

» top